Abstract
Original language | English |
---|---|
Pages (from-to) | 1021-1042 |
Number of pages | 22 |
Journal | Leukemia |
Publication status | Published or Issued - Feb 2019 |
Keywords
- B-cell non-Hodgkin lymphoma
- Childhood
- IL-15 superagonist
- adolescent
- cellular immunotherapy
- chimeric antigen receptor
- current perspectives
- non-Hodgkin lymphoma
- stem cell transplantation
- young adult
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Leukemia, 02.2019, p. 1021-1042.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
AU - Smitheman, Kimberly N.
AU - Severson, Tesa M.
AU - Rajapurkar, Satyajit R.
AU - McCabe, Michael T.
AU - Karpinich, Natalie
AU - Foley, James
AU - Pappalardi, Melissa B.
AU - Hughes, Ashley
AU - Halsey, Wendy
AU - Thomas, Elizabeth
AU - Traini, Christopher
AU - Federowicz, Kelly E.
AU - Laraio, Jenny
AU - Mobegi, Fredrick
AU - Ferron-Brady, Geraldine
AU - Prinjha, Rabinder K.
AU - Carpenter, Christopher L.
AU - Kruger, Ryan G.
AU - Wessels, Lodewyk
AU - Mohammad, Helai P.
AU - Hodson, Daniel J.
AU - Screen, Michael
AU - Turner, Martin
AU - Greinacher, Andreas
AU - Eekels, Julia J.M.
AU - Cairo, Mitchell S.
AU - Beishuizen, Auke
AU - Chu, Yaya
AU - Gardenswartz, Aliza
AU - Termuhlen, Amanda M.
AU - Cairo, Mitchell S.
AU - Frenquelli, M.
AU - Caridi, N.
AU - Antonini, E.
AU - Storti, F.
AU - Viganò, V.
AU - Gaviraghi, M.
AU - Occhionorelli, M.
AU - Bianchessi, S.
AU - Bongiovanni, L.
AU - Spinelli, A.
AU - Marcatti, M.
AU - Belloni, D.
AU - Ferrero, E.
AU - Karki, S.
AU - Brambilla, P.
AU - Martinelli-Boneschi, F.
AU - Colla, S.
AU - Ponzoni, M.
AU - DePinho, R. A.
AU - Tonon, G.
AU - Armenteros-Monterroso, Elena
AU - Zhao, Lu
AU - Gasparoli, Luca
AU - Brooks, Tony
AU - Pearce, Kerra
AU - Mansour, Marc R.
AU - Martens, Joost H. A.
AU - de Boer, Jasper
AU - Williams, Owen
AU - Adamia, Sophia
AU - Abiatari, Ivane
AU - Amin, Samir B.
AU - Fulciniti, Mariateresa
AU - Minvielle, Stephane
AU - Li, Cheng
AU - Moreau, Philippe
AU - Avet-Loiseau, Herve
AU - Munshi, Nikhil C.
AU - Anderson, Kenneth C.
AU - Angenendt, Linus
AU - Bormann, Eike
AU - Pabst, Caroline
AU - Alla, Vijay
AU - Görlich, Dennis
AU - Braun, Leonie
AU - Dohlich, Kim
AU - Schwöppe, Christian
AU - Bohlander, Stefan K
AU - Francisca, Maria
AU - Klaus, Arteaga
AU - Hartmann, Wolfgang
AU - Angenendt, Adrian
AU - Kessler, Torsten
AU - Mesters, Rolf M
AU - Stelljes, Matthias
AU - Löwenberg, Bob
AU - Serve, Hubert
AU - Georg, Carsten Müller-tidow
AU - Bernhard, Lenz
AU - Sauerland, M Christina
AU - Hiddemann, Wolfgang
AU - Berdel, Wolfgang E
AU - Krug, Utz
AU - Metzeler, Klaus H
AU - Herold, Jan-henrik Mikesch Tobias
AU - Schliemann, Christoph
AU - Herold, Tobias
AU - Tefferi, Ayalew
AU - Guglielmelli, Paola
PY - 2019/2
Y1 - 2019/2
N2 - Molecular causes of many inherited platelet disorders have been unraveled. Next generation sequencing facilitates diagnosis in 30-50% of patients. However, interpretation of genetic variants is challenging and requires careful evaluation in the context of the patient's phenotype. Before detailed testing is initiated, the treating physician and the patient should be aware why testing is performed and should agree on the consequences it may have, especially before testing for variants in genes associated with an increased risk for hematologic malignancies.
AB - Molecular causes of many inherited platelet disorders have been unraveled. Next generation sequencing facilitates diagnosis in 30-50% of patients. However, interpretation of genetic variants is challenging and requires careful evaluation in the context of the patient's phenotype. Before detailed testing is initiated, the treating physician and the patient should be aware why testing is performed and should agree on the consequences it may have, especially before testing for variants in genes associated with an increased risk for hematologic malignancies.
KW - B-cell non-Hodgkin lymphoma
KW - Childhood
KW - IL-15 superagonist
KW - adolescent
KW - cellular immunotherapy
KW - chimeric antigen receptor
KW - current perspectives
KW - non-Hodgkin lymphoma
KW - stem cell transplantation
KW - young adult
UR - http://www.mendeley.com/research/wnt-receptor-ror2-drives-interaction-multiple-myeloma-cells-microenvironment-through-akt-activation-1
M3 - Article
SN - 1476-5551
SP - 1021
EP - 1042
JO - Leukemia
JF - Leukemia
ER -